Clearmind Medicine receives Johns Hopkins approval for CMND-100 trial parts

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/2/2026

1. SPY
2. META
3. STZ
4. TSLA
5. FDS
6. HOOD
7. VEON
8. DOLE
9. LEVI
10. VANI

Go back to Clearmind Medicine receives Johns Hopkins approval for CMND-100 trial parts
(NASDAQ: CMND) Delayed: 2.30 --0 (-0%)
Previous Close $2.30    52 Week High $ 
Open $2.30    52 Week Low $ 
Day High $2.30    P/E N/A 
Day Low $2.30    EPS $ 
Volume 9,295